Development of a novel sheathless CE-ESI-MS interface via a CO2 laser ablated opening.
Talanta; doi.org/10.1016/j.talanta.2020.120853.
Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody.
Scientific Reports; doi.org/10.1073/pnas.1700239114.
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
Alzheimer’s Research & Therapy; doi.org/10.1186/s13195-020-00728-w.
Resveratrol-mediated cleavage of amyloid β1-42 peptide; potential relevance to Alzheimer’s disease.
Neurobiology of Aging; doi.org/10.1016/j.neurobiolaging.2020.04.012.
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: A pilot study.
bioRxiv; doi: doi.org/10.1101/2020.05.16.093559..
Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies.
Scientific Reports; doi.org/10.1038/s41598-020-77210-y.
A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms.
Frontiers in Molecular Biosciences; doi: 10.3389/fmolb.2020.00048.
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
Alzheimer’s Research & Therapy; https://doi.org/10.1186/s13195-020-00728-w.
Hsc70 Ameliorates the Vesicle Recycling Defects Caused by Excess α-Synuclein at Synapses.
ENEURO; DOI: https://doi.org/10.1523/ENEURO.0448-19.2020.
RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy.
Prion; doi: 10.1080/19336896.2020.1724608.